Published in J Immunol on January 15, 1991
Protective immune response against foot-and-mouth disease. J Virol (1992) 1.77
A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants. J Virol (1997) 1.36
Analysis of the human T-cell response to picornaviruses: identification of T-cell epitopes close to B-cell epitopes in poliovirus. J Virol (1993) 1.19
Enhanced mucosal immunoglobulin A response and solid protection against foot-and-mouth disease virus challenge induced by a novel dendrimeric peptide. J Virol (2008) 0.97
Identification of T-cell epitopes in nonstructural proteins of foot-and-mouth disease virus. J Virol (2001) 0.95
MHC class II restricted recognition of FMDV peptides by bovine T cells. Immunology (1991) 0.94
The influence of MHC polymorphism on the selection of T-cell determinants of FMDV in cattle. Immunology (1995) 0.93
Sequences derived from the highly antigenic VP1 region 140 to 160 of foot-and-mouth disease virus do not prime for a bovine T-cell response against intact virus. J Virol (1995) 0.92
Evidence of the coevolution of antigenicity and host cell tropism of foot-and-mouth disease virus in vivo. J Virol (2003) 0.90
Quantitation of Anaplasma marginale major surface protein (MSP)1a and MSP2 epitope-specific CD4+ T lymphocytes using bovine DRB3*1101 and DRB3*1201 tetramers. Immunogenetics (2006) 0.90
Interspecies major histocompatibility complex-restricted Th cell epitope on foot-and-mouth disease virus capsid protein VP4. J Virol (2000) 0.88
Proliferative lymphocyte responses to foot-and-mouth disease virus and three FMDV peptides after vaccination or immunization with these peptides in cattle. Immunology (1992) 0.88
Antibody response in mice inoculated with DNA expressing foot-and-mouth disease virus capsid proteins. J Virol (1998) 0.83
Induction of effective cross-reactive immunity by FMDV peptides is critically dependent upon specific MHC-peptide-T cell interactions. Immunology (1994) 0.83
Enhancement of serological immune responses to foot-and-mouth disease vaccine by a supplement made of extract of cochinchina momordica seeds. Clin Vaccine Immunol (2007) 0.83
Identification of major histocompatibility complex restriction and anchor residues of foot-and-mouth disease virus-derived bovine T-cell epitopes. J Virol (2009) 0.82
Lymphocyte recognition elements on the VP1 protein of Theiler's virus. Immunology (1995) 0.81
An overview on ELISA techniques for FMD. Virol J (2011) 0.80
New vaccine design based on defective genomes that combines features of attenuated and inactivated vaccines. PLoS One (2010) 0.79
Unprocessed foot-and-mouth disease virus capsid precursor displays discontinuous epitopes involved in viral neutralization. J Virol (1994) 0.79
Recombinant DNA and Protein Vaccines for Foot-and-mouth Disease Induce Humoral and Cellular Immune Responses in Mice. Immune Netw (2009) 0.78
Foot-and-mouth disease: overview of motives of disease spread and efficacy of available vaccines. J Anim Sci Technol (2015) 0.77
Cross-reactive and serotype-specific antibodies against foot-and-mouth disease virus generated by different regions of the same synthetic peptide. J Virol (1992) 0.77
Identification of H-2d restricted T cell epitope of foot-and-mouth disease virus structural protein VP1. Virol J (2011) 0.76
Immunogenicity of two FMDV nonameric peptides encapsulated in liposomes in mice and the protective efficacy in guinea pigs. PLoS One (2013) 0.75
Dendrimeric peptides can confer protection against foot-and-mouth disease virus in cattle. PLoS One (2017) 0.75
A re-appraisal of the biochemical map of foot-and-mouth disease virus RNA. J Gen Virol (1978) 2.06
Purification and identification of the RNA-dependent RNA polymerase of foot-and-mouth disease virus. J Gen Virol (1979) 1.50
Foot-and-mouth disease: the risk for Great Britain after 1992. Vet Rec (1992) 1.25
Tryptic peptide analysis of the structural proteins of vesicular stomatitis virus. J Gen Virol (1978) 1.24
A model for vesicular exanthema virus, the prototype of the calicivirus group. J Gen Virol (1978) 1.22
Thermal stability of foot-and-mouth disease virus. Arch Virol (1981) 1.22
Isotype responses of infected, virus-vaccinated and peptide-vaccinated cattle to foot-and-mouth disease virus. Vaccine (1990) 1.19
Moleculas aspects of the antigenic variation of swine vesicular disease and Coxsackie B5 viruses. J Gen Virol (1977) 1.10
T cell-dependent induction of antibody against foot-and-mouth disease virus in a mouse model. J Gen Virol (1989) 1.01
High-affinity antibody induced by immunization with a synthetic peptide is associated with protection of cattle against foot-and-mouth disease. Immunology (1991) 0.99
International bank for foot-and-mouth disease vaccine: assessment of Montanide ISA 25 and ISA 206, two commercially available oil adjuvants. Vaccine (1996) 0.98
Heterotypic recognition of foot-and-mouth disease virus by cattle lymphocytes. J Gen Virol (1990) 0.95
Heterotypic recognition of recombinant FMDV proteins by bovine T-cells: the polymerase (P3Dpol) as an immunodominant T-cell immunogen. Virus Res (1998) 0.95
MHC class II restricted recognition of FMDV peptides by bovine T cells. Immunology (1991) 0.94
Detection of foot-and-mouth disease viral sequences in clinical specimens and ethyleneimine-inactivated preparations by the polymerase chain reaction. Vaccine (1993) 0.93
Heterotypic protection induced by synthetic peptides corresponding to three serotypes of foot-and-mouth disease virus. J Virol (1990) 0.93
Biochemical aspects of variation in foot-and-mouth disease virus. J Gen Virol (1980) 0.91
The expression of the proteins of equine herpesvirus 1 which share homology with herpes simplex virus 1 glycoproteins H and L. Virus Res (1996) 0.91
Comparative immunogenicity of 146S, 75S and 12S particles of foot-and-mouth disease virus. Arch Virol (1982) 0.87
Metabolic effects of IGF-I in diabetic rats. Diabetes (1991) 0.87
Mechanism of IGF-I-stimulated glucose transport in human adipocytes. Demonstration of specific IGF-I receptors not involved in stimulation of glucose transport. Diabetes (1989) 0.86
Mouse protection test as a predictor of the protective capacity of synthetic foot-and-mouth disease vaccines. Vaccine (1991) 0.85
Synthetic peptide vaccines against foot-and-mouth disease. I. Duration of the immune response and priming in guinea-pigs, rabbits and mice. J Biol Stand (1987) 0.83
An international collaborative study on foot and mouth disease virus assay methods. 2. Quantification of 146S particles. J Biol Stand (1985) 0.82
Studies on glycoprotein 13 (gp13) of equid herpesvirus 1 using affinity-purified gp13, glycoprotein-specific monoclonal antibodies and synthetic peptides in a hamster model. J Gen Virol (1991) 0.81
Further developments in the quantification of small RNA viruses by U.V. photometry of sucrose density gradients. Dev Biol Stand (1981) 0.81
Synthetic peptide vaccines against foot-and-mouth disease. II. Comparison of the response of guinea-pigs, rabbits and mice to various formulations. J Biol Stand (1987) 0.80
Maturation of functional antibody affinity in animals immunised with synthetic foot-and-mouth disease virus. Res Vet Sci (1992) 0.79
Prospects for improved foot and mouth disease vaccines. Vaccine (1985) 0.78
The elution of foot-and-mouth disease virus from vaccines adjuvanted with aluminium hydroxide and with saponin. J Biol Stand (1982) 0.78
Stimulation of glucose uptake by insulin-like growth factor II in human muscle is not mediated by the insulin-like growth factor II/mannose 6-phosphate receptor. Biochem J (1994) 0.77
Induction of antibody to foot-and-mouth disease virus in presensitized mouse spleen cell cultures. J Virol (1984) 0.75
Observations and implications of proteolysis in preparations of foot-and-mouth disease virus. Dev Biol Stand (1981) 0.75
The detection and inhibition of proteolytic enzyme activity in concentrated preparations of inactivated foot-and-mouth disease virus. J Biol Stand (1983) 0.75
Qualitative assessment of 146 S particles of foot-and-mouth disease virus in preparations destined for vaccines. J Biol Stand (1982) 0.75
Isolation of capsid proteins of foot-and-mouth disease virus by chromatofocusing. J Virol Methods (1983) 0.75
The production and use of swine vesicular disease virus from pig kidney monolayer cells grown on the surface of 3-mm-diameter glass spheres. Biotechnol Bioeng (1982) 0.75
[Effects of temperature and inactivators on strains of foot-and-mouth disease virus in Colombia]. Rev Latinoam Microbiol (1984) 0.75
The evaluation of a physical method for the quantification of inactivated poliovirus particles and its relationship to D-antigenicity and potency testing in rats. J Biol Stand (1984) 0.75
A comparative study of the surface projections of different strains of vesicular stomatitis virus. J Gen Virol (1975) 0.75
The stability and potency of vaccines prepared from inactivated foot-and-mouth disease virus concentrates. J Biol Stand (1984) 0.75
Synthesis of the protected tridecapeptide (56-68) of the VH domain of mouse myeloma immunoglobulin M603 and its reattachment to resin supports. Int J Pept Protein Res (1983) 0.75
Interactions between saponin and 146S particles of foot-and-mouth disease virus. J Biol Stand (1982) 0.75